



| 04-02-2010: | Foreign drug makers may lose monopoly |
| 13-01-2010: | Strides Made in Lung Cancer Treatment |
| 13-01-2010: | AET, CI, UNH, WLP, HUM, OSIP, BWS, OEH, CAT Popular Stocks |
| 30-12-2009: | Pfizer ends late-stage lung-cancer study |
| 24-12-2009: | Research Yields New Agent For Some Drug-Resistant Non-small Cell Lung Cancers |
| 24-12-2009: | Lung cancer: New drug shows promise in lab mice |
| 18-12-2009: | DAN, JAH, TOT, OSIP, RHHBY, HITK, SNIC, NBY, ACL Popular Stocks |
| 18-12-2009: | FDA Advisory Committee Recommends Against Approving Tarceva For First-Line Maintenance Use In Advanced Non-Small Cell Lung Cancer |
| 17-12-2009: | US FDA panel rejects early use of Tarceva |
| 19-11-2009: | MethylGene Reports Favorable Phase I Data For MGCD265 In Solid Tumors At The AACR-NCI-EORTC International Conference |
| 10-10-2009: | Pfizer halts enrollment in lung cancer trial |
| 08-10-2009: | African American Lung Cancer Patients May Have Different Response To New Cancer-fighting Drugs |
| 01-10-2009: | Synta Pharmaceuticals Initiates Fourth Trial Of STA-9090, A Novel Synthetic Small Molecule Hsp90 Inhibitor |
| 30-09-2009: | Paul Marks Prize Recognizes Three Young Cancer Researchers |
Cancer Drugs & Treatments Diagnosed With Cancer? Learn About Available Treatments at CTCA. www.CancerCenter.com
Erlotinib for Research 1 g $42; 5 g $159 -- Bulk Also See Competitors' Purity/Prices Here www.LCLabs.com
Erlotinib 99% Pure, EGFR Kinase Inhibitor Lowest price, -- Bulk Also in stock www.selleckchem.com





